JAMA 2 May 2007 Vol 297

7 May, 07 | by BMJ Group

SURVIVE is not a good acronym for a trial of inotropic drugs in decompensated heart failure: if there is one certainty in cardiac pharmacology, it is that inotropic drugs never improve survival. They usually have the opposite effect. This was a large trial of patients who “required inotropic support

You may leave a response but pinging is currently not allowed.

Posted in Comment, Richard Lehman's weekly review of medical journals.

Respond

Print page

Rights and permissions

By submitting your comment you agree to adhere to these terms and conditions

You can follow any responses to this entry through the RSS 2.0 feed.

BMJ.com

Helping doctors make better decisions. Visit site

Tags
AIDS alcohol bmj Cancer climate change death depression developing countries Diabetes ethics exercise general practice global health GP commissioning HIV Human Rights India Israel JAMA journalology Junior doctors Lancet mental health MSF NCDs NEJM NHS NHS reform NHS reforms obesity palliative care peer review pregnancy Primary Care public health publishing research social media sports medicine surgery Swine flu technology twitter US healthcare WHO
Categories
BMJ Group blogs

BMJ Group blogs

BMJ